Matches in Wikidata for { <http://www.wikidata.org/entity/Q53632238> ?p ?o ?g. }
- Q53632238 description "2016 nî lūn-bûn" @default.
- Q53632238 description "2016年の論文" @default.
- Q53632238 description "2016年学术文章" @default.
- Q53632238 description "2016年学术文章" @default.
- Q53632238 description "2016年学术文章" @default.
- Q53632238 description "2016年学术文章" @default.
- Q53632238 description "2016年学术文章" @default.
- Q53632238 description "2016年學術文章" @default.
- Q53632238 description "2016年學術文章" @default.
- Q53632238 description "2016年學術文章" @default.
- Q53632238 description "2016年學術文章" @default.
- Q53632238 description "2016年學術文章" @default.
- Q53632238 description "2016年學術文章" @default.
- Q53632238 description "2016년 논문" @default.
- Q53632238 description "article científic" @default.
- Q53632238 description "article scientific" @default.
- Q53632238 description "article scientifique (publié 2016)" @default.
- Q53632238 description "articol științific" @default.
- Q53632238 description "articolo scientifico" @default.
- Q53632238 description "artigo científico (publicado na 2016)" @default.
- Q53632238 description "artigo científico (publicado na 2016)" @default.
- Q53632238 description "artigo científico" @default.
- Q53632238 description "artikull shkencor" @default.
- Q53632238 description "artikulong pang-agham" @default.
- Q53632238 description "artykuł naukowy" @default.
- Q53632238 description "artículo científico publicado en 2016" @default.
- Q53632238 description "artículu científicu" @default.
- Q53632238 description "bilimsel makale" @default.
- Q53632238 description "bài báo khoa học" @default.
- Q53632238 description "mokslinis straipsnis" @default.
- Q53632238 description "naučni članak" @default.
- Q53632238 description "scienca artikolo" @default.
- Q53632238 description "scientific article" @default.
- Q53632238 description "teaduslik artikkel" @default.
- Q53632238 description "tieteellinen artikkeli" @default.
- Q53632238 description "tudományos cikk" @default.
- Q53632238 description "vedecký článok" @default.
- Q53632238 description "vetenskaplig artikel" @default.
- Q53632238 description "videnskabelig artikel (udgivet 2016)" @default.
- Q53632238 description "vitenskapelig artikkel" @default.
- Q53632238 description "vitskapeleg artikkel" @default.
- Q53632238 description "vědecký článek" @default.
- Q53632238 description "wetenschappelijk artikel" @default.
- Q53632238 description "wissenschaftlicher Artikel" @default.
- Q53632238 description "επιστημονικό άρθρο" @default.
- Q53632238 description "мақолаи илмӣ" @default.
- Q53632238 description "мақолаи илмӣ" @default.
- Q53632238 description "наукова стаття, опублікована в жовтні 2016" @default.
- Q53632238 description "научна статия" @default.
- Q53632238 description "научная статья" @default.
- Q53632238 description "научни чланак" @default.
- Q53632238 description "научни чланак" @default.
- Q53632238 description "գիտական հոդված" @default.
- Q53632238 description "מאמר מדעי" @default.
- Q53632238 description "سائنسی مضمون" @default.
- Q53632238 description "مقالة علمية" @default.
- Q53632238 description "مقالهٔ علمی" @default.
- Q53632238 description "২০১৬-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q53632238 description "บทความทางวิทยาศาสตร์" @default.
- Q53632238 description "სამეცნიერო სტატია" @default.
- Q53632238 name "PS01.58: A Phase 3 Trial of Nivolumab, Nivolumab Plus Ipilimumab, or Placebo Maintenance for Extensive-Stage SCLC After First-Line Chemotherapy: Topic: Medical Oncology." @default.
- Q53632238 name "PS01.58: A Phase 3 Trial of Nivolumab, Nivolumab Plus Ipilimumab, or Placebo Maintenance for Extensive-Stage SCLC After First-Line Chemotherapy: Topic: Medical Oncology." @default.
- Q53632238 type Item @default.
- Q53632238 label "PS01.58: A Phase 3 Trial of Nivolumab, Nivolumab Plus Ipilimumab, or Placebo Maintenance for Extensive-Stage SCLC After First-Line Chemotherapy: Topic: Medical Oncology." @default.
- Q53632238 label "PS01.58: A Phase 3 Trial of Nivolumab, Nivolumab Plus Ipilimumab, or Placebo Maintenance for Extensive-Stage SCLC After First-Line Chemotherapy: Topic: Medical Oncology." @default.
- Q53632238 prefLabel "PS01.58: A Phase 3 Trial of Nivolumab, Nivolumab Plus Ipilimumab, or Placebo Maintenance for Extensive-Stage SCLC After First-Line Chemotherapy: Topic: Medical Oncology." @default.
- Q53632238 prefLabel "PS01.58: A Phase 3 Trial of Nivolumab, Nivolumab Plus Ipilimumab, or Placebo Maintenance for Extensive-Stage SCLC After First-Line Chemotherapy: Topic: Medical Oncology." @default.
- Q53632238 P1433 Q53632238-0C78761E-39AB-4E4B-925C-B7FD85FEDE4F @default.
- Q53632238 P1476 Q53632238-C877B276-CBD4-4708-B883-26199391DC21 @default.
- Q53632238 P2093 Q53632238-31567E8C-7EA9-4ACA-A934-FC81F29A0EA8 @default.
- Q53632238 P2093 Q53632238-33775761-8664-4636-BEF2-B1CF577255DD @default.
- Q53632238 P2093 Q53632238-42B6DCAC-4456-42B5-8C61-461DEF205C17 @default.
- Q53632238 P2093 Q53632238-593B2536-2779-4FD2-BEBA-405304768A6C @default.
- Q53632238 P2093 Q53632238-A416127B-2FC9-45A6-AA26-47AF41CF208E @default.
- Q53632238 P2093 Q53632238-B88D4AE7-0FA9-4B74-9B7E-BC2A751ABDAA @default.
- Q53632238 P2093 Q53632238-C157DC54-E5E6-4345-BB3B-6DD31974A08E @default.
- Q53632238 P2093 Q53632238-CDF1BB15-27E7-47B5-8F89-315DC5811AFA @default.
- Q53632238 P304 Q53632238-48202C61-E8FD-4756-AC6E-ED4D752A471B @default.
- Q53632238 P31 Q53632238-3B360783-2119-421C-8241-19E06934141D @default.
- Q53632238 P356 Q53632238-17A27652-57F6-45EE-B295-0BBBCC7C78D4 @default.
- Q53632238 P433 Q53632238-E0F8AEBF-4235-4CD9-9A5F-94B2DAF3E119 @default.
- Q53632238 P478 Q53632238-749D91BF-1626-44CA-A39D-69476819060B @default.
- Q53632238 P50 Q53632238-CD1930EA-5FAB-4A1B-A94E-18F8DB0969D4 @default.
- Q53632238 P577 Q53632238-94ABAD87-0B83-4524-93E7-CFB0525B2F95 @default.
- Q53632238 P921 Q53632238-0732B540-6485-4456-839A-DB8C83C3ECDE @default.
- Q53632238 P921 Q53632238-21DEAAAB-CC71-49FF-84CB-FC4545EA363A @default.
- Q53632238 P921 Q53632238-AB2A8A2F-3E83-418B-9784-1E5AC621A3F1 @default.
- Q53632238 P356 J.JTHO.2016.09.093 @default.
- Q53632238 P1433 Q2448056 @default.
- Q53632238 P1476 "PS01.58: A Phase 3 Trial of Nivolumab, Nivolumab Plus Ipilimumab, or Placebo Maintenance for Extensive-Stage SCLC After First-Line Chemotherapy: Topic: Medical Oncology." @default.
- Q53632238 P2093 "Anne Pieters" @default.
- Q53632238 P2093 "Giovanni Selvaggi" @default.
- Q53632238 P2093 "Justin Fairchild" @default.
- Q53632238 P2093 "Martin Reck" @default.
- Q53632238 P2093 "Neal Ready" @default.
- Q53632238 P2093 "Ramaswamy Govindan" @default.
- Q53632238 P2093 "Solange Peters" @default.
- Q53632238 P2093 "Taofeek Owonikoko" @default.
- Q53632238 P304 "S306-S307" @default.
- Q53632238 P31 Q13442814 @default.